Prof. Dr. Emel Ceylan

Prof. Dr. Emel Ceylan
Academic Title :
Prof. Dr.

Prof. Dr. Emel Ceylan is a distinguished Nuclear Medicine specialist at Liv Hospital Ulus in Istanbul, possessing over twenty years of extensive experience in nuclear oncology, molecular imaging, and targeted radionuclide therapies.

Education and Academic Qualifications

  • Medical Degree (MD) from Hacettepe University Faculty of Medicine, 1993 - 1999.
  • Specialization in Nuclear Medicine from the Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, 2000 - 2004.
  • Clinical Fellowship in PET-MR from the Imaging Unit at Essen University in Germany, July 2015.

Areas of Interest

  • Nuclear Oncology
  • Radionuclide Therapies (such as Lutetium-177 and Actinium-225)
  • Advanced Molecular Imaging
  • Routine Nuclear Medicine Applications and Scans
  • PET/CT and PET/MR Imaging Techniques
  • Thyroid Diseases, Thyroid Cancer, and Radioiodine Therapy (Atom Therapy)
  • Professor and Specialist, Department of Nuclear Medicine, Liv Hospital Ulus in Istanbul, 2018 - Present.
  • Associate Professor and Head of the Nuclear Medicine Department, Sisli Florence Nightingale Hospital and Istanbul Bilim University, 2015 - 2018.
  • Associate Professor and Head of the Nuclear Medicine Department, Mersin University Faculty of Medicine, 2012 - 2015.
  • Assistant Professor and Head of the Nuclear Medicine Department (Founding Physician), Mersin University Faculty of Medicine, 2006 - 2012.
  • Invited Guest Assistant Professor, Department of Nuclear Medicine, Near East University, June 2010.
  • Specialist Physician and Founder of the Scintigraphy Unit, Private Denge Medical Center in Ankara, 2004 - 2006.
  • Specialist Physician, Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, April - October 2004.
  • Turkish Nuclear Medicine Association (Member of Cardiology and Oncology Working Groups)
  • European Association of Nuclear Medicine (EANM)
  • Editorial and Advisory Board Member for several specialized scientific and medical journals in molecular imaging and nuclear medicine
  • Published a research paper on pediatric neuroblastoma imaging guidelines in Nuclear Medicine Seminars in 2020.
  • Co-authored the Renal Cortical Scintigraphy Procedure Guideline and patient dosimetry protocols published in 2020.
  • Published a study on the clinical advantages of using E-PSMA in prostate cancer patients in Molecular Oncologic Imaging in 2023.
  • Published an article on the role of diffusion-weighted MRI in evaluating nodular thyroid diseases in Mersin University Journal of Health Sciences in 2019.
  • Authored and co-authored several clinical chapters and research papers on the staging and management of esophageal, lung, and gastrointestinal cancers using nuclear medicine.
Share :